Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01020012 | CE(20:2) | Lipid-depleted/compactin | 0.0 | BCD100427B02 | 1.52 | pmol/sample |
| LMST01020012 | CE(20:2) | Lipid-depleted/compactin | 0.5 | BCD100427B05 | 2.67 | pmol/sample |
| LMST01020012 | CE(20:2) | Lipid-depleted/compactin | 1.0 | BCD100427B09 | - | pmol/sample |
| LMST01020012 | CE(20:2) | Lipid-depleted/compactin | 2.0 | BCD100427B13 | 3.13 | pmol/sample |
| LMST01020012 | CE(20:2) | Lipid-depleted/compactin | 4.0 | BCD100427B17 | 1.47 | pmol/sample |
| LMST01020012 | CE(20:2) | Lipid-depleted/compactin | 8.0 | BCD100427B21 | 1.17 | pmol/sample |
| LMST01020012 | CE(20:2) | Lipid-depleted/compactin | 12.0 | BCD100427B25 | 1.02 | pmol/sample |
| LMST01020012 | CE(20:2) | Lipid-depleted/compactin | 24.0 | BCD100427B29 | - | pmol/sample |
| LMST01020012 | CE(20:2) | C | 0.0 | BCD100427B01 | 1.28 | pmol/sample |
| LMST01020012 | CE(20:2) | C | 0.5 | BCD100427B03 | 1.26 | pmol/sample |
| LMST01020012 | CE(20:2) | C | 1.0 | BCD100427B07 | 1.31 | pmol/sample |
| LMST01020012 | CE(20:2) | C | 2.0 | BCD100427B11 | 1.17 | pmol/sample |
| LMST01020012 | CE(20:2) | C | 4.0 | BCD100427B15 | 1.34 | pmol/sample |
| LMST01020012 | CE(20:2) | C | 8.0 | BCD100427B19 | - | pmol/sample |
| LMST01020012 | CE(20:2) | C | 12.0 | BCD100427B23 | 2.22 | pmol/sample |
| LMST01020012 | CE(20:2) | C | 24.0 | BCD100427B27 | - | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B06 | 1.83 | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B10 | 1.77 | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B14 | 3.12 | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B18 | 2.17 | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B22 | 4.58 | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B26 | 9.62 | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B30 | 8.26 | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol | 0.5 | BCD100427B04 | - | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol | 1.0 | BCD100427B08 | 1.72 | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol | 2.0 | BCD100427B12 | 2.04 | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol | 4.0 | BCD100427B16 | 2.22 | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol | 8.0 | BCD100427B20 | 4.19 | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol | 12.0 | BCD100427B24 | 3.6 | pmol/sample |
| LMST01020012 | CE(20:2) | 25OH-Chol | 24.0 | BCD100427B28 | 3.49 | pmol/sample |